Phase I/Ii, Double-Blind, Placebo-Controlled, Multi-Dose Escalation Trial of a Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody (MEDI-493) in Children Hospitalized With RSV • 906
Pediatric Research - United States
doi 10.1203/00006450-199804001-00927
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 1998
Authors
Publisher
Springer Science and Business Media LLC